Navigation Links
Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies
Date:2/8/2011

SEATTLE, Washington, February 8, 2011 The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.

Two of the four new grants are aimed at producing novel tests to diagnose or monitor disease. Jane Burns at Seattle Children's Hospital, in conjunction with Enertechnix, a Washington-based company, will adapt a novel air sampling device to collect exhaled breath for non-invasive detection of lung infections. Patrick Stayton at the University of Washington will develop new reagents to increase the speed and sensitivity of laboratory tests (known as immunoassays) used for diagnosing and monitoring disorders such as cancer and heart disease.

The remaining two grants focus on better management of neurological conditions. Christopher Bernards at Benaroya Research Institute at Virginia Mason will test a device, developed by the University of Washington and Seattle-based Impel NeuroPharma, that delivers drugs directly to the brain, potentially reducing harmful side effects. Barry Lutz at the University of Washington will use his award to develop an improved drainage system to reduce intracranial pressure in patients with brain disorders or trauma.

The awards were made in the second round of the 2010 commercialization grant competition, which promotes the translation of promising technologies from Washington's non-profit research sector into marketable products and services having the power to improve health, foster economic growth, and enhance life sciences competitiveness in the state.

"The Board of Trustees was particularly impressed with the 'platform potential' of these awards," noted LSDF executive director Lee Huntsman. "These are multi-application technologies. Even though the LSDF grant may focus on use for a single purpose, such as detecting bacteria in cystic fibrosis patients or reducing pain, each technology could have much broader applicability for diagnosing or treating a wide array of patients. This significantly enhances the potential for commercial success and for improving health and health care in Washington and beyond."

Commercialization grants are intended to boost technologies trapped in the so-called "valley of death" (that portion of the product development cycle in which funding is the most difficult to obtain) and make them more amenable to funding from the private sector. Tom Clement, Director of New Ventures-Life Sciences at the University of Washington Center for Commercialization (C4C), stated that "LSDF commercialization grants are a key component of C4C's mission of moving research discoveries out of the lab and into people's lives. These grants support proof-of-concept studies and other critical activities that help our Entrepreneurs-in-Residence and other expert advisors guide research outcomes into products to improve human health."

The four awards were chosen from the 10 proposals received in the competition. A panel of national experts convened by the American Association for the Advancement of Science evaluated the scientific and technical merit of the projects, while a panel of commercialization experts assessed each project's commercial potential and possible health and economic benefits. The LSDF Board of Trustees made the final award selections.

According to Lura Powell, chair of the LSDF Board of Trustees, getting new technologies into widespread use usually includes forming new companies or establishing partnerships with existing companies. Each of the four awards involves or anticipates the launch of a Washington-based company, in line with LSDF's mission to enhance the Washington economy. "These young technologies will not have an impact on human health without company involvement. We are pleased to use our commercialization grant funding to both move the technologies forward and encourage the development of Washington's for-profit life sciences sector," she stated.


'/>"/>

Contact: Cathy Manner
manner@lsdfa.org
206-732-6755
Life Sciences Discovery Fund
Source:Eurekalert

Related medicine news :

1. Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
2. Highlights of major physics conference in Washington, D.C.
3. Vancouver, Washington -- Free Family Fun at Health Fair
4. Ricochet PR Names Valerie Carter Vice President of Washington, D.C. Public Affairs Practice
5. New Insurance Membership Program Protects Washington State Families Against High Cost of Emergency Medical Transports
6. Brain Injury Association of Washington Provides National Leadership in Concussion Safety & Awareness
7. AMA Honors Washington State Secretary of Health With Top Government Service Award
8. Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says
9. LazyTown Sportacus and Michelle Obama moves Washington DC
10. IntraHealth International Opens Washington, D.C. Office
11. DC Dermatologist Dr. Susan T. Elliott Selected Best Doctor by Washingtonian Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient system, ... potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... , April 24, 2017 Solentim, ... today announced the addition of a major new ... In-situ Plate Seeding,). The VIPS has been developed ... 384 well microplates as part of the process ... offers a simple and more reliable solution when ...
(Date:4/20/2017)... PLANO, Texas , April 20, 2017  Vivify ... via mobile devices, has been awarded a very significant ... care via EMRs to continual care via digital health. ... of key intellectual property and further secures Vivify,s position ... Vivify, launched in 2009, was the first company to ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology: